|
2025-02-05 |
2025-02-04 |
VP
Vente planifiée
|
Naftzger J. Christopher
General Counsel and CCO
Dirigeant
|
11 333
-11.6%
3,28
37 206 USD
|
11 333
-11.6%
|
3,28
|
37 206 USD
|
|
|
2025-02-05 |
2025-02-04 |
VP
Vente planifiée
|
Sims Karen
Chief Medical Officer
Dirigeant
|
19 348
-15.4%
3,28
63 519 USD
|
19 348
-15.4%
|
3,28
|
63 519 USD
|
|
|
2025-02-05 |
2025-02-04 |
VP
Vente planifiée
|
McElhaugh Michael J.
Interim President & CEO
Administrateur exécutif
|
23 790
-1.6%
3,28
78 103 USD
|
23 790
-1.6%
|
3,28
|
78 103 USD
|
|
|
2025-02-05 |
2025-02-04 |
VP
Vente planifiée
|
HASTINGS DAVID C
Chief Financial Officer
Dirigeant
|
22 183
-12.2%
3,28
72 827 USD
|
22 183
-12.2%
|
3,28
|
72 827 USD
|
|
|
2024-08-16 |
2024-08-14 |
V
Vente
|
MANCHESTER KEITH S
Administrateur non-exécutif
|
8 846
-16.1%
3,69
32 637 USD
|
8 846
-16.1%
|
3,69
|
32 637 USD
|
|
|
2024-02-05 |
2024-02-02 |
VP
Vente planifiée
|
HASTINGS DAVID C
Chief Financial Officer
Dirigeant
|
9 593
-5.0%
2,31
22 184 USD
|
9 593
-5.0%
|
2,31
|
22 184 USD
|
|
|
2024-02-05 |
2024-02-02 |
VP
Vente planifiée
|
Sofia Michael J.
Chief Scientific Officer
Dirigeant
|
9 982
-0.7%
2,31
23 083 USD
|
9 982
-0.7%
|
2,31
|
23 083 USD
|
|
|
2024-02-05 |
2024-02-02 |
VP
Vente planifiée
|
McElhaugh Michael J.
Interim President & CEO
Administrateur exécutif
|
10 164
-0.7%
2,31
23 504 USD
|
10 164
-0.7%
|
2,31
|
23 504 USD
|
|
|
2024-02-05 |
2024-02-02 |
VP
Vente planifiée
|
Sims Karen
Chief Medical Officer
Dirigeant
|
4 358
-3.4%
2,31
10 078 USD
|
4 358
-3.4%
|
2,31
|
10 078 USD
|
|
|
2021-12-03 |
2021-12-01 |
VP
Vente planifiée
|
Sofia Michael J.
Chief Scientific Officer
Dirigeant
|
200 000
-13.3%
5,09
1 018 000 USD
|
200 000
-13.3%
|
5,09
|
1 018 000 USD
|
|
|
2021-02-10 |
2021-02-09 |
VP
Vente planifiée
|
McElhaugh Michael J.
Chief Business Officer
Dirigeant
|
20 000
-1.5%
5,00
100 000 USD
|
20 000
-1.5%
|
5,00
|
100 000 USD
|
|
|
2020-12-16 |
2020-12-14 |
VP
Vente planifiée
|
McElhaugh Michael J.
Chief Business Officer
Dirigeant
|
10 000
-0.7%
5,00
50 032 USD
|
10 000
-0.7%
|
5,00
|
50 032 USD
|
|
|
2020-12-16 |
2020-12-14 |
VP
Vente planifiée
|
McElhaugh Michael J.
Chief Business Officer
Dirigeant
|
30 000
-2.2%
5,00
150 000 USD
|
30 000
-2.2%
|
5,00
|
150 000 USD
|
|
|
2020-07-27 |
2020-07-23 |
VP
Vente planifiée
|
McElhaugh Michael J.
Chief Business Officer
Dirigeant
|
20 000
-1.4%
5,01
100 200 USD
|
20 000
-1.4%
|
5,01
|
100 200 USD
|
|
|
2018-08-14 |
2018-08-13 |
V
Vente
|
Sofia Michael J.
Chief Scientific Officer
Dirigeant
|
4 250
-0.3%
9,51
40 436 USD
|
4 250
-0.3%
|
9,51
|
40 436 USD
|
|
|
2018-07-13 |
2018-07-11 |
VP
Vente planifiée
|
Sofia Michael J.
Chief Scientific Officer
Dirigeant
|
10 000
-0.7%
10,00
100 000 USD
|
10 000
-0.7%
|
10,00
|
100 000 USD
|
|
|
2018-07-10 |
2018-07-09 |
VP
Vente planifiée
|
Sofia Michael J.
Chief Scientific Officer
Dirigeant
|
10 000
-0.7%
8,91
89 060 USD
|
10 000
-0.7%
|
8,91
|
89 060 USD
|
|
|
2018-07-10 |
2018-07-06 |
VP
Vente planifiée
|
Sofia Michael J.
Chief Scientific Officer
Dirigeant
|
10 000
-0.7%
8,45
84 500 USD
|
10 000
-0.7%
|
8,45
|
84 500 USD
|
|
|
2018-07-06 |
2018-07-05 |
VP
Vente planifiée
|
Sofia Michael J.
Chief Scientific Officer
Dirigeant
|
10 000
-0.6%
8,40
84 000 USD
|
10 000
-0.6%
|
8,40
|
84 000 USD
|
|
|
2018-07-06 |
2018-07-03 |
VP
Vente planifiée
|
Sofia Michael J.
Chief Scientific Officer
Dirigeant
|
10 000
-0.6%
8,00
80 000 USD
|
10 000
-0.6%
|
8,00
|
80 000 USD
|
|
|
2017-10-05 |
2017-10-03 |
VP
Vente planifiée
|
Sofia Michael J.
Chief Scientific Officer
Dirigeant
|
10 000
-0.6%
8,00
80 000 USD
|
10 000
-0.6%
|
8,00
|
80 000 USD
|
|
|
2017-08-17 |
2017-08-15 |
V
Vente
|
Sofia Michael J.
Chief Scientific Officer
|
20 000
-10.4%
3,68
73 500 USD
|
20 000
-10.4%
|
3,68
|
73 500 USD
|
|
|
2017-08-17 |
2017-08-15 |
V
Vente
|
Sofia Michael J.
Chief Scientific Officer
|
10 000
-5.0%
3,75
37 500 USD
|
10 000
-5.0%
|
3,75
|
37 500 USD
|
|
|
2015-08-26 |
2015-08-24 |
A
Achat
|
HENRIQUES RICHARD C JR
Administrateur non-exécutif
|
1 000
+inf%
6,95
6 950 USD
|
1 000
+inf%
|
6,95
|
6 950 USD
|
|
